Herbal acupuncture needles aim to ease Crash-Related knee pain
NCT ID NCT06931951
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding herbal acupuncture to standard oriental medicine treatments can better relieve acute knee pain from traffic accidents. Forty adults hospitalized with knee pain (rated 5 or higher on a 0-10 scale) will be randomly assigned to receive either herbal acupuncture plus standard care or standard care alone. The main goal is to see if the herbal acupuncture group reports less pain after treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- herbal extract-based pharmacopuncture (injected into acupuncture points)
- What this could lead to
- If it works, this could offer a non-drug option for quickly easing knee pain after a car accident.
- What could go wrong
- This is a very small pilot study with only 40 people, so results may not apply widely. It compares two similar treatments, so a big difference is unlikely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 to 69 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * When the NRS (Numeric Rating Scale) of knee pain caused by a traffic accident is 5 or higher. * Patients hospitalized for traffic accident treatment. * Patients with acute pain within 14 days of experiencing knee pain due to a traffic accident. * Patients aged between 19 and 70 years old. * participants who agree to participate in clinical research and provide written test subject consent. Exclusion Criteria: * For patients diagnosed with a specific serious disease that may cause knee pain (acute fracture, dislocation, complete rupture of ligaments, etc.) * If the cause of the pain is caused by a disease other than the knee (tumor, fibromyalgia, rheumatoid arthritis, gout, lumbar disc herniation, etc.) * Cases where surgical intervention is required due to suspected acute fracture, dislocation, or ligament and cartilage damage * If there is another acute disease (stroke, myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.) that may interfere with the treatment effect or interpretation of results * Patients currently taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect their findings * Inadequate or unsafe medication: hemorrhagic disease, anticoagulant therapy, severe diabetic patients with risk of infection * Patients who have taken drugs that may affect pain, such as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or have received herbal acupuncture or physical therapy within the past week * In the case of pregnant women and in the case of planning to become pregnant or nursing * Patients within 3 months after knee surgery or if knee replacement surgery was performed * If it has been less than 1 month since participants finished participating in another clinical study, or if participants are planning to participate in another clinical study during the study participation and follow-up period within 6 months from the date of selection * If it is difficult to fill out the consent form for research participation * In cases where it is difficult for other researchers to participate in clinical research
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pharmacologic action are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Daejeon Jaseng Hospital of Korean Medicine
RECRUITINGDaejeon, South Korea